Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: Vomitoxin, 4-Deoxynivalenol

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $89 | In Stock | In Stock | |
| 5 mg | $328 | In Stock | In Stock | |
| 10 mg | $543 | In Stock | In Stock | |
| 25 mg | $896 | In Stock | In Stock |
| Description | Deoxynivalenol (Vomitoxin) is an orally active mycotoxin belonging to the trichothecenes family, which traverses the intestinal mucosa via the paracellular pathway without being affected by P-gp/MRP, used for research on gastrointestinal inflammation such as diarrhea and vomiting. |
| Targets & IC50 | COLO 201 cells:86 μM, IPEC-J2 cells:25.93 ± 5.13 μM (72 h), IPEC-J2 cells:44.83 ± 6.14 μM (48 h), K562 cells:1010 nM (EC50) |
| In vitro | Methods: IPEC-J2 cells were incubated with 0–12 μmol/L Deoxynivalenol (DON) for 24 hours. Cell viability was measured by CCK-8 assay, monolayer permeability was assessed by FITC-dextran method, cell apoptosis was observed by TUNEL staining, and the expression and distribution of ZO-1 and F-actin were detected by immunofluorescence. Results: DON concentration-dependently reduced cell viability, increased monolayer permeability, induced cell apoptosis, and disrupted tight junction structures associated with ZO-1 and F-actin. [1] Methods: IPEC-J2 cells were incubated with 100 ng/mL Deoxynivalenol (DON) for 24–72 hours. Cell viability and proliferation were detected by MTT and EdU assays, and protein expression was determined by Western blotting and immunofluorescence. Results: DON inhibited cell viability and proliferation, downregulated p-mTOR, p-S6K1, and p-S6 expression, and upregulated TSC2 expression, indicating that DON affects cellular function through the TSC2/mTORC1 pathway.[2] |
| In vivo | Methods: To investigate the developmental toxicity of Deoxynivalenol, pregnant rats were administered Deoxynivalenol (0–5 mg/kg) by gavage once daily for 14 consecutive days, with observation of salivation symptoms and fetal skeletal development. Results: Deoxynivalenol increased the number of pregnant rats with excessive salivation in a dose-related manner; at a dose of 5 mg/kg, it caused abnormal sternal development in rat fetuses. [3] Methods: Prepubertal (21-day-old) and adult (65-day-old) female Swiss mice were selected and fed diets containing 10 mg/kg Deoxynivalenol (DON) for 15 or 28 days, respectively; the control group was fed mycotoxin-free diets. Results: Deoxynivalenol (DON) induced ovarian tissue damage, altered serum follicle-stimulating hormone levels, and triggered age-dependent inflammatory responses and oxidative stress. [4] |
| Synonyms | Vomitoxin, 4-Deoxynivalenol |
| Molecular Weight | 296.32 |
| Formula | C15H20O6 |
| Cas No. | 51481-10-8 |
| Smiles | CC1=C[C@H]2O[C@@H]3[C@H](O)C[C@@](C)([C@]33CO3)[C@@]2(CO)[C@H](O)C1=O |
| Relative Density. | 1.48g/cm3 |
| Storage | Store at low temperature,Keep away from moisture,Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 260 mg/mL (877.43 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (16.87 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.